• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

• 페이스북 공유
• 트위터 공유
• 

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. There aren't many studies regarding how exposure over time may affect a pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to evaluate the benefits of using it against the potential risks to the fetus. Physicians don't have the data to give clear advice but they can provide information about risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers used a large population-based study of case control to assess the frequency of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to ensure that the classification was correct and to eliminate any bias.

The study of the researchers had some limitations. Researchers were unable to, in the first place to differentiate the effects caused by the medication from the disorder. This makes it difficult for researchers to determine whether the small associations observed among the groups exposed were due to the use of medication, or if they were caused by co-morbidities. The researchers did not study long-term outcomes for the offspring.

The study did find that infants whose mothers had taken ADHD medications during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or stopped their medications before or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risks associated with the use adhd non stimulant medication uk medications in early pregnancies may be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman's disorder. Physicians should speak with their patients about this issue and as much as possible, assist them improve coping skills which may reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether or not to stop treatment during pregnancy is one that more and more physicians confront. The majority of these decisions are taken in the absence of any evidence that is clear and definitive either way, so physicians have to weigh their experience, the experiences of other doctors, and what adhd medications are there uk research says on the topic, along with their own best judgment for each patient.

The issue of potential risks for infants can be difficult to determine. A lot of studies on this topic are based on observational data rather than controlled research and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which may undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study presented in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion: While some studies have found a positive association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies show a neutral or even slightly negative effect. In each case, a careful analysis of the potential risks and benefits is required.

For many women with ADHD, the decision to stop taking medication can be difficult, if not impossible. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for these patients. A decrease in medication could also affect the ability to safely drive and complete work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.

She suggests that women who are unsure whether to take the medication or discontinue it due to pregnancy, educate their family members, colleagues, and their friends about the condition, the effects on daily functioning, and the advantages of staying on the current treatment. In addition, educating them can aid in ensuring that the woman feels supported when she is struggling with her decision. It is important to note that certain drugs can pass through the placenta so if the patient decides to stop taking her adhd Inattentive type medication medication during pregnancy and breastfeeding, she must be aware that the effects of the drug could be transferred to the infant.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the drugs could have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers behind the study found no connection between the use of early medications and congenital abnormalities like facial clefting, or club foot. The results are in line with previous studies showing a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of the time of pregnancy. The risk was higher in the latter half of pregnancy, as many women decide to stop taking their ADHD medication.

Women who took ADHD medication in the first trimester were more likely to require a caesarean birth or have an insufficient Apgar after birth and have a baby that needed breathing assistance after birth. However the researchers of the study were not able to eliminate selection bias by restricting the study to women who did not have any other medical conditions that could be a contributing factor to these findings.

Researchers hope that their study will help doctors when they meet pregnant women. They advise that while the discussion of the risks and benefits is crucial however, the decision to stop or maintain medication must be based on each woman's needs and the severity of her adhd otc medication symptoms.

The authors also warn that even though stopping the medication is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health problems in women who are pregnant or post-partum. Further, research shows that women who stop taking their medications will have a difficult time adjusting to a life without them once the baby is born.

Nursing

It can be overwhelming becoming a mother. Women who suffer from ADHD who have to manage their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. Therefore, many women elect to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines are absorbed through breast milk in small quantities, so the risk to breastfeeding infant is minimal. However, the amount of exposure to medications by the newborn can vary depending on dosage, frequency it is administered and the time of the day the medication is administered. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn is not fully known.

Because of the lack of research, some physicians may be inclined to discontinue stimulant drugs during the course of pregnancy. It's a difficult choice for the mother, who must weigh the advantages of taking her medication as well as the risk to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their history of ADHD and whether they are planning or taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication safely while breastfeeding and during pregnancy. In the end, an increasing number of patients choose to do so, and in consultation with their doctor they have found that the benefits of keeping their current medication outweigh any risks.

It's important for women with ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD be aware of their symptoms and underlying disorder Learn about the available treatment options and strengthen existing coping strategies. This should be a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both mother and child, as well as monitoring for signs of deterioration and the need for adjustments to the medication regimen.